hearing aid caregiver training

Each Ear LLC Announces Free Community Outreach Tool: Basic Hearing Aid Training for Caregivers™

HALES CORNERS, WISCONSIN –  Each Ear, LLC is announcing Basic Hearing Aid Training for Caregivers™,  a new community outreach tool for hearing aid clinics, designed to build new and fortify existing relationships with local nursing homes and assistive living facilities. Basic Hearing Aid Training for Caregivers™, a 40-minute video course, is a public service of…

Read More
asha otc comments fda

ASHA Comments on Draft Regulations For Over-the-Counter Hearing Aids

ROCKVILLE, MARYLAND — Stressing the need for safety and for the pre-purchase of audiological assessment, the American Speech-Language-Hearing Association (ASHA) today submitted comments to the U.S. Food and Drug Administration (FDA) concerning draft regulations for over-the-counter (OTC) hearing aids, a new category of medical devices intended for persons with mild-to-moderate hearing loss. These OTC devices…

Read More
sonova acquires alpaca audiology

Sonova to Acquire Alpaca Audiology Network

STAFA, SWITZERLAND – Sonova Holding AG, a leading provider of hearing care solutions, has signed an agreement to acquire Alpaca Audiology, one of the largest independent networks of audiological care clinics in the US. Founded in 2011, the company has over 500 employees and operates around 220 clinics across the country. The purchase price amounts…

Read More
neuromod otologie tinnitus

Neuromod Launches Ótologie to Provide Specialist Telehealth Service for Tinnitus Patients

DUBLIN, IRELAND — Medical device company, Neuromod Devices Ltd, has launched Ótologie, a specialist telehealth service for tinnitus. This new service will provide tinnitus patients, throughout the United Kingdom and Europe, with a private care option to avoid waiting lists and give them immediate access to treatment from its telehealth service. The establishment of Ótologie…

Read More

FDA approves Cochlear Nucleus Implants for Unilateral Hearing Loss/Single-Sided Deafness

LONE TREE, COLORADO — Cochlear Limited (ASX: COH), a global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval of Cochlear™ Nucleus® Implants for the treatment of unilateral hearing loss (UHL)/single-sided deafness (SSD).   Cochlear implants are already FDA approved for those with moderate to profound bilateral sensorineural hearing loss. With…

Read More
cognivue aib partnership

Cognivue Announces Partnership with American Institute of Balance to Expand Cognitive Screening

ROCHESTER, NEW YORK — Neuroscience company Cognivue, Inc. has partnered with American Institute of Balance (AIB) to make its cognitive screening products and services available to the AIB provider network of certified physicians, audiologists, and physical therapists. AIB is recognized as the leading diagnostic, treatment, and educational research center in vestibular and equilibrium sciences in the United States.…

Read More
oticon medical ponto 5 superpower

Oticon Medical Announces FDA Clearance of Ponto 5 SuperPower

SOMERSET, NEW JERSEY – Oticon Medical announces that the U.S. Food and Drug Administration (FDA) has cleared the new Ponto 5 SuperPower sound processor, expanding the Ponto 5 family product line. According to the announcement, the device would be the smallest SuperPower device available, which also delivers “significant advancements in sound processor technology – including…

Read More
hearing aid caregiver training

Basic Hearing Aid Training for Caregivers™, Each Ear LLC Announces Free Video Training 

HALES CORNERS, WISCONSIN – Each Ear, LLC today announced the unveiling of the caregiver training  video, Basic Hearing Aid Training for Caregivers™, a no-cost 40-minute video course covering:   1. Consistent hearing aid wearing  2. The various styles of hearing aids  3. Powering hearing aids on and off  4. Safeguarding hearing aids and loss prevention   5. Hearing…

Read More
otonomy hearing loss drug

Otonomy Reports Corporate and Product Pipeline Update

SAN DIEGO, CALIFORNIA — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today provided an update on its product pipeline and financial guidance. Consistent with previously stated timing, the company expects to report results for the Phase 2a cohort of OTO-413 in hearing loss patients early in…

Read More